Efficacy and Safety of Maralixibat (SHP625) in the Treatment of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC)

Condition:   Cholestasis Interventions:   Drug: Maralixibat;   Drug: Placebo Sponsor:   Shire Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials